These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17157627)

  • 1. Ovarian cancer.
    Mironov S; Akin O; Pandit-Taskar N; Hann LE
    Radiol Clin North Am; 2007 Jan; 45(1):149-66. PubMed ID: 17157627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging techniques for the evaluation of ovarian cancer.
    Fischerova D; Burgetova A
    Best Pract Res Clin Obstet Gynaecol; 2014 Jul; 28(5):697-720. PubMed ID: 24846098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging].
    Bochev P; Bocheva Y; Klisarova A; Ivanov S; Dancheva J; Chaushev B
    Akush Ginekol (Sofiia); 2012; 51(1):18-27. PubMed ID: 22639775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer: detection and radiologic staging.
    Shaaban A; Rezvani M
    Clin Obstet Gynecol; 2009 Mar; 52(1):73-93. PubMed ID: 19179862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidisciplinary approach to ovarian cancer at diagnosis.
    Spencer JA
    Br J Radiol; 2005; 78 Spec No 2():S94-102. PubMed ID: 16306641
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of prostate cancer.
    Akin O; Hricak H
    Radiol Clin North Am; 2007 Jan; 45(1):207-22. PubMed ID: 17157630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CT in the evaluation of ovarian malignancy.
    Amendola MA
    Crit Rev Diagn Imaging; 1985; 24(4):329-68. PubMed ID: 3896652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET for management of cervical and ovarian cancer.
    Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
    Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovaries.
    Kainz C; Prayer L; Gitsch G; Stiglbauer R; Kramer J; Reinthaller A; Kölbl H
    J Am Coll Surg; 1994 Mar; 178(3):239-44. PubMed ID: 8149015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of uterine cancer.
    Akin O; Mironov S; Pandit-Taskar N; Hann LE
    Radiol Clin North Am; 2007 Jan; 45(1):167-82. PubMed ID: 17157628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
    Makhija S; Howden N; Edwards R; Kelley J; Townsend DW; Meltzer CC
    Gynecol Oncol; 2002 Apr; 85(1):53-8. PubMed ID: 11925120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging breast cancer.
    Bartella L; Smith CS; Dershaw DD; Liberman L
    Radiol Clin North Am; 2007 Jan; 45(1):45-67. PubMed ID: 17157623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of bladder cancer.
    Zhang J; Gerst S; Lefkowitz RA; Bach A
    Radiol Clin North Am; 2007 Jan; 45(1):183-205. PubMed ID: 17157629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
    Bristow RE; Giuntoli RL; Pannu HK; Schulick RD; Fishman EK; Wahl RL
    Gynecol Oncol; 2005 Nov; 99(2):294-300. PubMed ID: 16051330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and interventional radiology in gynecologic neoplasms.
    Thorvinger B
    Acta Radiol Suppl; 1992; 378 ( Pt 3)():93-108. PubMed ID: 1323200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.